Bamco Inc. NY Purchases New Holdings in Heartflow, Inc. $HTFL

Bamco Inc. NY acquired a new position in Heartflow, Inc. (NASDAQ:HTFL) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,225,133 shares of the company’s stock, valued at approximately $94,625,000.

A number of other hedge funds have also made changes to their positions in HTFL. TrueMark Investments LLC lifted its position in shares of Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after acquiring an additional 379 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in Heartflow in the 4th quarter valued at $27,000. Strs Ohio raised its stake in Heartflow by 35.3% in the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after purchasing an additional 1,200 shares during the last quarter. Russell Investments Group Ltd. purchased a new position in Heartflow in the 4th quarter valued at $45,000. Finally, Legal & General Group Plc acquired a new stake in Heartflow during the 3rd quarter worth $59,000.

Insider Activity at Heartflow

In related news, insider Campbell Rogers sold 9,219 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the transaction, the insider owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the completion of the sale, the chief executive officer owned 457,935 shares of the company’s stock, valued at $16,027,725. This trade represents a 7.83% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 191,271 shares of company stock worth $7,089,136. Company insiders own 7.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. increased their target price on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Benchmark restated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research note on Friday, August 14th. Piper Sandler reissued an “overweight” rating and issued a $45.00 target price (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Finally, Wells Fargo & Company boosted their target price on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Trading Down 1.9%

NASDAQ HTFL opened at $48.94 on Thursday. The stock has a fifty day simple moving average of $31.68 and a 200-day simple moving average of $28.79. The stock has a market cap of $4.26 billion and a PE ratio of -26.74. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $51.19.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Research analysts predict that Heartflow, Inc. will post -0.75 EPS for the current year.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.